Depressive Disorder, Treatment-Resistant: all 472 studies

Page 5 of 5. Open to participants first (151), then studies with results posted, then the rest; newest registration first within each.

• Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant DepressionCompletedNCT03109717
• An Epidemiology Study of Treatment Resistant Depression in the United States (US)CompletedNCT03109002
• Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant DepressionCompletedNCT03027362Not applicable
• Lithium Versus Quetiapine in Treatment Resistant DepressionStatus unknownNCT03004521Phase 4
• Treatment Resistant Depression and Insomnia in Older VeteransCompletedNCT02971150Not applicable
• Adaptive tDCS for Treatment-Resistant MDDTerminatedNCT02942368Phase 1
• Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)CompletedNCT02911597Phase 1
• Deep Brain Stimulation to Relieve DepressionWithdrawnNCT02889250Phase 3
• Clinical Trial on Efficacy of rTMS to Improve ECT in Treatment-Resistant DepressionCompletedNCT02830399Not applicable
• Effects of TBS on 5-HT1A Receptor BindingStatus unknownNCT02810717Not applicable
• D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant DepressionStatus unknownNCT02772211Phase 4
• Epidemiology of Treatment Resistant Depression in TaiwanCompletedNCT02691520
• Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant DepressionTerminatedNCT02675556Phase 1
• Clinical Trial of the Use of Ketamine in Treatment Resistant DepressionStatus unknownNCT02610712Phase 4
• Ketamine Infusions for PTSD and Treatment-Resistant DepressionCompletedNCT02577250Phase 1
• Efficacy of Deep Transcranial Magnetic Stimulation (TMS) for Treatment-resistant Depression and Neuroanatomical Correlates: a Clinical Study Coupled With Positon Emission Tomography (PET)CompletedNCT02559466Not applicable
• Focal Electrically Administered Seizure Therapy for the Treatment of DepressionStatus unknownNCT02462551Not applicable
• Adjunct Minocyline in Treatment-resistant DepressionCompletedNCT02456948Phase 2
• Maintenance rTMS for Treatment-resistant Depression (TRD): a One-year Double Blind Controlled StudyStatus unknownNCT02383693Phase 2/3
• Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled TrialCompletedNCT02263872Phase 4
• PINS Stimulator System for Patients With Treatment Resistant DepressionStatus unknownNCT02253355Early Phase 1
• Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive TherapyWithdrawnNCT02238730Not applicable
• Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentCompletedNCT02153502Phase 2
• Implementation Trial of Evidence Based Practices for Mood DisordersCompletedNCT02150577Not applicable
• Comparison of Anodal Transcranial Direct Current Stimulation (t-DCS) and Sham Stimulation in Patients With Treatment-resistant DepressionCompletedNCT02141776Phase 4
• Deep Brain Stimulation (DBS) Therapy for Treatment Resistant DepressionActive, not recruitingNCT02046330Not applicable
• Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+SActive, not recruitingNCT01984710Not applicable
• DBS for Treatment Resistant DepressionCompletedNCT01983904Not applicable
• Deep Brain Stimulation in Patients With Chronic Treatment Resistant DepressionCompletedNCT01973478Not applicable
• Action of Ketamine in Treatment-Resistant DepressionCompletedNCT01945047Phase 2/3
• Comparing Ketamine and Propofol Anesthesia for Electroconvulsive TherapyCompletedNCT01935115Phase 4
• Interpersonal Psychotherapy for Treatment Resistant DepressionStatus unknownNCT01896349Not applicable
• Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican PopulationStatus unknownNCT01868802Phase 2
• A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant DepressionStatus unknownNCT01801319Not applicable
• DBS of the Lateral Habenula in Treatment-Resistant DepressionActive, not recruitingNCT01798407Not applicable
• Evaluating the Efficacy of Magnetic Seizure Therapy in Treatment Resistant Depression.WithdrawnNCT01748708Not applicable
• Coupling Repetitive Transcranial Magnetic Stimulation With a Neuronavigation System in Treatment Resistant DepressionCompletedNCT01677078Not applicable
• A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant DepressionCompletedNCT01640080Phase 2
• Functional and Neurochemical Correlates of Treatment Response in Major Depressive DisorderTerminatedNCT01598324
• Magnesium Sulfate Versus 5% Dextrose With Treatment Resistant DepressionCompletedNCT01597167Not applicable
• Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive DisorderCompletedNCT01596608Not applicable
• A Study of BCI-838 and Several BCI-632 Prodrugs in Healthy VolunteersCompletedNCT01546051Phase 1
• Sequential Left Prefrontal Repetitive Transcranial Magnetic Stimulation, With High Frequency, for Treatment-Resistant DepressionStatus unknownNCT01469325Not applicable
• An Open Label Study of the Genecept™ Assay in Treatment Resistant DepressionWithdrawnNCT01438242Not applicable
• Deep Brain Stimulation in Treatment Resistant DepressionStatus unknownNCT01435148Not applicable
• Exercise in Treatment Resistant Depression (TRD): A Feasibility StudyCompletedNCT01383811Not applicable
• Pulsating ElectroMagnetive Treatment (PEMF) at Treatment Resistant DepressionCompletedNCT01353092Phase 3
• Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant DepressionCompletedNCT01282632Phase 1/2
• Efficacy, Safety and Tolerability of CX157 in Treatment Resistant DepressionCompletedNCT01246908Phase 2
• Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot StudyStatus unknownNCT01239888Phase 1
• Brain MRI (Magnetic Resonance Imaging) Scans of Patients With Treatment Resistant Depression (TRD) and Healthy ControlsCompletedNCT01162434
• Halifax Treatment Refractory Depression TrialCompletedNCT01141426Not applicable
• Safety and Efficacy of EVT 101 in Treatment-Resistant DepressionTerminatedNCT01128452Phase 2
• A Study of RO4917523 in Patients With Treatment Resistant DepressionCompletedNCT00809562Phase 2
• A Pilot Study of the Use of Magnetic Seizure Therapy for DepressionCompletedNCT00808938Phase 2
• Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic PolymorphismCompletedNCT00704860Phase 4
• Transcranial Direct Current Stimulation (tDCS) in Treatment-resistant DepressionCompletedNCT00667680Phase 2
• Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive TherapyCompletedNCT00664976Not applicable
• Ketamine Frequency Treatment for Major Depressive DisorderWithdrawnNCT00646087Phase 4
• Berlin Deep Brain Stimulation Depression StudyCompletedNCT00531726Not applicable
• Treatment Resistant Depression and Obstructive Sleep Apnea, Effect of Continuous Positive Airway Pressure (CPAP)Status unknownNCT00441636Not applicable
• Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory DepressionTerminatedNCT00296686Phase 4
• Aripiprazole Augmentation Therapy in Treatment-resistant DepressionWithdrawnNCT00276978Phase 3
• Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled TrialWithdrawnNCT00273624Phase 3
• Venlafaxine Augmentation in Treatment Resistant DepressionCompletedNCT00253266Phase 4
• Use of Risperidone in ECT for Treatment Resistant DepressionTerminatedNCT00203723Phase 4
• Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression (rTMS)TerminatedNCT00190216Phase 3
• Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant DepressionCompletedNCT00179244Phase 3
• Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI TreatmentWithdrawnNCT00178854Phase 4
• An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant DepressionCompletedNCT00070694Phase 2
• A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant DepressionCompletedNCT00044681Phase 3
• The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant DepressionCompletedNCT00035321Phase 3

← Depressive Disorder, Treatment-Resistant overview